Published

Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Clinical pharmacology and therapeutics
Date: 2023-04-01
Source: PubMed
DOI: 10.1002/cpt.2821
PubMed: 36507738

Authors

Holze F Becker AM Kolaczynska KE Duthaler U Liechti ME

Watch author

Derived topics and classifications

psilocybin psilocin Pharmacology Clinical Trial Healthy Volunteers Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 14 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement2026-12-01 Psilocybin as serotonergic therapy in epilepsy: Narrative review of potentials and limitations2026-07-21 Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants2026-07-01 Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intake2026-05-23 The magic of mushrooms: psilocybin influences behavior in the mangrove rivulus fish, Kryptolebias marmoratus2026-05-07 Synthesis and Characterization of Psilocybin Metabolites and Deuterated Analogs2026-03-18 Efficient Acyloxymethylation of Psilocin and Other Tryptamines Yielding ACOM Prodrugs for Psychedelic-Assisted Therapy2025-07-01 Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans2025-04-21 Elucidating the Phase I metabolism of psilocin in vitro2025-03-01 Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis2025-01-01 Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry method2024-08-01 In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin2024-04-29 In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin2024-01-08 Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants.2023-04-01

Related papers

A Phase 1 Study Comparing the Pharmacokinetics and Safety of Intravenous and Oral PsilocybinClinicalTrials.gov · 2023-05-15 Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy VolunteersClinicalTrials.gov · 2026-02-05 A Phase 1 Study of a Second Psilocybin Group Retreat for Partial Responders With Anxiety Associated With Metastatic CancerClinicalTrials.gov · 2025-10-14 2 x 2 Factorial, Double-blind, Randomized Trial of 'Set and Setting': a Translational Study in Healthy VolunteersClinicalTrials.gov · 2026-06-04 Engaging Mood Brain Circuits With Psilocybin: a Randomized Neuroimaging Trial in DepressionClinicalTrials.gov · 2026-03-30 A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Oral Psilocybin (TRP-8802) Administration in Concert With Psychotherapy Among Adult Patients With Irritable Bowel Syndrome: A Randomized Delayed Treatment Control DesignClinicalTrials.gov · 2026-02-05 Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of LifeClinicalTrials.gov · 2025-11-25 A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Psilocybin Administration in Concert With Psychotherapy Among Adult Patients With FibromyalgiaClinicalTrials.gov · 2025-04-16